Bupropion (amfebutamone): French pharmacovigilance data.
D000799:Angioedema / Q000139:chemically induced; D016642:Bupropion / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced; D005602:France; D006801:Humans; D006967:Hypersensitivity; D012640:Seizures / Q000139:chemically induced; D016540:Smoking Cessation; D013405:Suicide
D016642:Bupropion